PRIMARY BILIARY CIRRHOSIS: DIAGNOSTIC CRITERIA AND THE AUTHORS’ EXPERIENCE WITH THERAPY
- 作者: Khlynov I.1, Chlkunova M.1
-
隶属关系:
- Ural State Medical University
- 期: 卷 26, 编号 1 (2015)
- 页面: 44-46
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116174
- ID: 116174
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The incidence rate of primary biliary cirrhosis (PBC) is 4 to 40 per 100,000 in people of different ethnicities. The basic morphological substrate of the disease is autoimmune nonpurulent destructive cholangitis characterized by the development of clinical and laboratory intrahepatic cholestasis. The treatment of PBC involves mandatory long use of ursodeoxycholic acid (UDCA) in a dose of 13-15 mg/kg/day. The authors’ experience with UDCA in the retrospective investigation demonstrates it necessary to study the clinical efficacy of its preparations in randomized controlled prospective trials.
全文:
作者简介
I. Khlynov
Ural State Medical University
Email: hlinov.doc@yandex.ru
MD
M. Chlkunova
Ural State Medical UniversityCandidate of Medical Sciences
参考
- Parikh-Patel A., Gold E., Worman H. et al. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States // Hepatology. - 2001; 33: 16-21.
- Howel D., Fischbacher C., Bhopal R. et al. An exploratory population-based case-control study of primary biliary cirrhosis // Hepatology. - 2000; 31: 105560.
- Sood S., Gow P., Christie J. et al. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations // Gastroenterology. -2004; 127: 470-5.
- Bittencourt P., Farias A., Abrantes-Lemos C. et al. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis // J. Gastroenterol. Hepatol. - 2004; 19: 873-8.
- Selmi C., Mayo M., Bach N. et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment // Gastroenterology. -2004; 127: 485-92.
- Locke G. III, Therneau T., Ludwig J. et al. Time course of histological progression in primary biliary cirrhosis // Hepatology. - 1996; 23: 52-6.
- Corpechot C., Carrat F., Bonnand A. et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis // Hepatology. -2000; 32: 1196-9.
- Corpechot C., Carrat F., Bahr A. et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis // Gastroenterology. -2005; 128: 297-303.
- Scheuer P. Primary biliary cirrhosis // Proc. R. Soc. Med. - 1967; 60: 1257-60.
- Ивашкин В.Т., Широкова Е.Н., Маевская М.В. и др. Клинические рекомендации по диагностике и лечению холестаза. 2013; 37 с. [Электронный ресурс]. URL: http://www.rsls.ru (дата обращения: 14.12.2014)
补充文件
